中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2014年
8期
55-57
,共3页
轻型脑损伤%磁敏感加权成像%脑微出血
輕型腦損傷%磁敏感加權成像%腦微齣血
경형뇌손상%자민감가권성상%뇌미출혈
Mild brain injury%Susceptibility weighted imaging%Cerebral microbleed
目的 探讨3.0T MRI磁敏感加权成像(SwI)技术对轻型脑损伤(MBI)的早期诊断.方法 对周口市中心医院神经外科收治的42例入院时头颅CT阴性的MBI患者在入院48 h内行3.0T MRI-SWI序列检查,明确脑微出血灶(CMB)的部位、数量等.结果 42例中CMB位于皮层18例(42.9%),脑白质14例(33.3%),胼胝体7例(16.7%),基底节及脑干3例(7.1%);CMB数量单发20例(47.6%),2个14例(33.3%),多发8例(19.1%).结论 SWI为头颅CT阴性的MBI患者提供了确切的早期诊断依据,且量化了CMB的程度和范围,结合伤后昏迷时间明确了原发性脑损伤的鉴别诊断,为MBI的临床治疗及预后评估提供了直接的影像学基础.
目的 探討3.0T MRI磁敏感加權成像(SwI)技術對輕型腦損傷(MBI)的早期診斷.方法 對週口市中心醫院神經外科收治的42例入院時頭顱CT陰性的MBI患者在入院48 h內行3.0T MRI-SWI序列檢查,明確腦微齣血竈(CMB)的部位、數量等.結果 42例中CMB位于皮層18例(42.9%),腦白質14例(33.3%),胼胝體7例(16.7%),基底節及腦榦3例(7.1%);CMB數量單髮20例(47.6%),2箇14例(33.3%),多髮8例(19.1%).結論 SWI為頭顱CT陰性的MBI患者提供瞭確切的早期診斷依據,且量化瞭CMB的程度和範圍,結閤傷後昏迷時間明確瞭原髮性腦損傷的鑒彆診斷,為MBI的臨床治療及預後評估提供瞭直接的影像學基礎.
목적 탐토3.0T MRI자민감가권성상(SwI)기술대경형뇌손상(MBI)적조기진단.방법 대주구시중심의원신경외과수치적42례입원시두로CT음성적MBI환자재입원48 h내행3.0T MRI-SWI서렬검사,명학뇌미출혈조(CMB)적부위、수량등.결과 42례중CMB위우피층18례(42.9%),뇌백질14례(33.3%),변지체7례(16.7%),기저절급뇌간3례(7.1%);CMB수량단발20례(47.6%),2개14례(33.3%),다발8례(19.1%).결론 SWI위두로CT음성적MBI환자제공료학절적조기진단의거,차양화료CMB적정도화범위,결합상후혼미시간명학료원발성뇌손상적감별진단,위MBI적림상치료급예후평고제공료직접적영상학기출.
Objective To investigate the early diagnosis of mild brain injury (MBI) by 3.0T MRI susceptibility weighted imaging (SWI).Methods Forty-two cases of MBI in Zhoukou central hospital with negative head CT were examined by 3.0T MRI-SWI in 48 hours and identified location and quantity of cerebral microbleed(CMB).Results In 42 cases,18 cases (42.9%) with CMB located in the cortex,14 cases (33.3%) located in alba,7 cases(16.7%) located in corpus callosum,3 cases (7.1%) located in basal nucleid and brainstem.As to the quantities of CMB,20 cases (47.6%) were single,14 cases (33.3%) were double,8 cases(19.1%) were more than three.Conclusions SWI exactly provides early diagnosis with negative head CT and quantifies degree and range of CMB,it identifies the differential diagnosis of primary brain injury together with coma time postinjury.It also provides first-hand iconography for clinical therapy and evaluating prognosis.